Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
IPCA Laboratories Limited (NSE: IPCALAB), ISIN INE571A01038 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
IPCALAB last traded at ₹1958.30 (+0.85%), with a 52-week range of ₹1293.90 to ₹2038.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 44.72%, FIIs 11.53%, DIIs 36.60%, mutual funds 31.07%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.